Try our mobile app

General information

Country: UNITED STATES

Sector: Oil and Gas E and P

  • Dividend yield for the last twelve months 3.1%
  • Free cash flow yield -19.9% (LTM)
  • Share price is 53.3% higher than minimum and 91.8% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (4.6x vs
    )

Key Financials (Download financials)

Ticker: CRC
Share price, USD:  (0.0%)49.68
year average price 48.05  


year start price 52.47 2024-08-31

max close price 59.59 2024-11-22

min close price 32.40 2025-04-08

current price 49.68 2025-08-31
Common stocks: 81 879 504

Dividend Yield:  3.1%
FCF Yield LTM: -19.9%
EV / LTM EBITDA: 4.6x
EV / EBITDA annualized: 7.2x
Target EV / EBITDA (hist percentile):
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 4 068
Net Debt ($m): 938
EV (Enterprise Value): 5 006
EBITDA LTM ($m): 1 099
EV / LTM EBITDA: 4.6x
Price to Book: 1.1x
Potential alt: 0.0%

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2025-08-19newsfilecorp.com

CSE Bulletin: Consolidation - Canter Resources Corp. (CRC)

2025-08-18newsfilecorp.com

Canter Resources Announces Effective Date for Share Consolidation

2025-08-16marketbeat.com

3 Energy Stocks to Gain Exposure to the Carbon Capture Boom

2025-08-06seekingalpha.com

California Resources Corporation (CRC) Q2 2025 Earnings Call Transcript

2025-08-05zacks.com

California Resources Corporation (CRC) Q2 Earnings and Revenues Surpass Estimates

2025-08-05globenewswire.com

California Resources Corporation Reports Second Quarter 2025 Financial and Operating Results

2025-07-21zacks.com

Strength Seen in California Resources (CRC): Can Its 6.7% Jump Turn into More Strength?

2025-05-12globenewswire.com

CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)

2025-05-07seekingalpha.com

California Resources Corporation (CRC) Q1 2025 Earnings Call Transcript

2025-03-14benzinga.com

California Resources Faces Permit Challenges And Oversupply Risks—Analyst Sees Growth, But Stay Cautious
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company